Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Haynes W. Sheppard"'
Autor:
Caroline J. Chantry, Barbara F. Abrams, Richard M. Donovan, Kiersten A. Israel-Ballard, Haynes W. Sheppard
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2006 (2006)
Externí odkaz:
https://doaj.org/article/0382f7ad075a4ba3b63baee58ed30313
Publikováno v:
Chemokine Receptors and AIDS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388198407bc681aa94372e49b82691c5
https://doi.org/10.1201/9780429074974-11
https://doi.org/10.1201/9780429074974-11
Autor:
Haynes W. Sheppard, Burton P. Dorman
Publikováno v:
AIDS. 29:125-127
Autor:
Haynes W. Sheppard, Jack DeHovitz, Eric Delwart, Mardge H. Cohen, Elizabeth T. Golub, Michael P. Busch, Flavien Bernardin, Ruth M. Greenblatt, Susan Buchbinder, Albert Y. Liu, Jason D. Barbour, Marek Nowicki, Valerie Winkelman, Tzong-Hae Lee, Chenglong Liu, Katryn Anastos
Publikováno v:
AIDS. 25:619-623
Objective: Transient HIV infections have been invoked to account for the cellular immune responses detected in highly virus-exposed individuals who have remained HIV-seronegative. We tested for very low levels of HIV RNA in 524 seronegative plasma sa
Autor:
Yasuhiro Nishiyama, Hiroaki Taguchi, Yukie Mitsuda, Haynes W. Sheppard, Sudhir Paul, Miguel A. Escobar, Robert A. Kyle, Carl V. Hanson, Mary Kate Morris, Maria Salas, Robert L. Hunter, Stephanie Planque, Pablo C. Okhuysen
Publikováno v:
AIDS Research and Human Retroviruses. 23:1541-1554
Antibody hydrolysis of the superantigenic gp120 site and HIV-1 neutralization was studied as a potential anti-HIV mechanism in uninfected humans. gp120 hydrolysis by purified serum and salivary antibodies was determined by electrophoresis and peptide
Autor:
Barbara Abrams, Kiersten A. Israel-Ballard, Lindiwe Sibeko, Haynes W. Sheppard, Anna Coutsoudis, Caroline J. Chantry, Richard M. Donovan
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 45:318-323
Up to 40% of all mother-to-child transmission of HIV occurs by means of breast-feeding; yet in developing countries infant formula may not be a safe option. The World Health Organization recommends heat-treated breast milk as an infant-feeding altern
Autor:
Haynes W. Sheppard, María A. Pando, María M. Avila, Mercedes Weissenbacher, María Luz Osimani, Jorge Benetucci, Silvia M. Montano, Jose C. Russi, Liliana Martinez-Peralta, Moira Vignoles, Hector Chiparelli, Diana Rossi, José Luis Sánchez, Sergio Maulen, Sergio Sosa-Estani
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 42:494-500
Using the serological testing algorithm for recent HIV seroconversion, we estimated annualized incidences (per 100 person-years) of HIV-1 infection in different at-risk groups in Buenos Aires and Montevideo, during a 5-year period between 1998 and 20
Autor:
Haynes W. Sheppard, James R. Carlson, Barbara Abrams, Richard M. Donovan, Bo Lönnerdal, Kiersten A. Israel-Ballard, Caroline J. Chantry, Kathryn G. Dewey, Allyson C Sage
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 40:175-181
Allyson Sage, RN, MPH,¶ and Barbara Abrams, DrPH# Background: Heat-treated breast milk of HIV-positive mothers has potential to reduce vertical transmission. This study compared the impact of flash-heating (FH) and Pretoria pasteurization (PP) on HI
Autor:
Haynes W. Sheppard
Publikováno v:
Current Drug Target -Infectious Disorders. 5:131-141
Inactivated or "killed" virus (KV) is a "classical" approach that has produced safe and effective human and veterinary vaccines but has received relatively little attention in the effort to develop an HIV/AIDS vaccine. Initially, KV and rgp120 subuni
Autor:
Susan Allen, Taha E. Taha, Huyen Cao, Rosemary Musonda, Lynn S. Zijenah, James McIntyre, Ruben Filter, Glenda Gray, Clive M. Gray, Haynes W. Sheppard, Helba Bredell, Jorge Flores, Newton Kumwenda, Lynn Morris, Carolyn Williamson, Efthyia Vardas, Adrian Puren, Salim S. Abdool Karim, Xiaohua Xia, Mike Mbizo, M. Colvin, David Katzenstein
Publikováno v:
AIDS Research and Human Retroviruses. 21:285-291
Defining viral dynamics in natural infection is prognostic of disease progression and could prove to be important for vaccine trial design as viremia may be a likely secondary end point in phase III HIV efficacy trials. There are limited data availab